icon-    folder.gif   Conference Reports for NATAP  
 
  International AIDS Conference
Durban, South Africa
July 18-22 2016
Back grey_arrow_rt.gif
 
 
 
12-week raltegravir-intensified quadruple therapy versus triple first-line ART reduces viral load more rapidly but does not reduce mortality in severely immunosuppressed African HIV-infected adults and older children: the REALITY trial
 
 
  Reported by Jules Levin
Durban 2016 IAS July 18-22
 
Cissy Kityo, Abraham Siika, Alexander J. Szubert, Jane Mallewa, Mutsa
Bwakura-Dangarembizi, Sheila Kabahenda, Shalton Mwaringa, Sarah L. Pett, Anna Griffiths, Abbas Lugemwa, Simon Wachira, Godfrey Musoro, Chatu Rajapakse, Timothy Etyang, James Abach, Priscilla Wavamunno, Linda Nyondo-Mipando, Andrew Reid, Kusum Nathoo, James Hakim, Diana M. Gibb, A. Sarah Walker and the REALITY trial team

IAC1

IAC2

IAC3

IAC4

IAC5